All Collaboration articles – Page 6
-
BusinessUS to invest $160m in cancer partnership
Funds will be backed up with $55m from 11 companies to advance new cancer treatments that harness the immune system
-
NewsResearchGate under pressure to restrict article sharing
International STM publisher group appears poised to take legal action against researchers’ networking site for copyright violations
-
-
OpinionCollaboration and competition can both stimulate innovation
Diverse approaches suit different goals
-
NewsGlobal science collaborations rocket
International research partnerships more than doubled in the last 15 years with the number of nations involved nearly tripling
-
BusinessUniversity–industry collaborations aspire to pharmaceutical innovation
Three new UK partnerships illustrate drug research co-operation approaches that are growing in popularity
-
CareersTime to lose chemistry’s subdisciplines?
Organic, inorganic and physical – do they mean anything in modern chemistry?
-
NewsCut red tape to help innovation boom, says German chemistry sector
Leading organisations call for less bureaucracy and more funding to improve collaboration between universities and industry
-
-
NewsTrump presidency could hinder US–Mexico scientific collaboration
Bilaterial collaboration threatened by Republican candidate’s stance on border wall
-
OpinionChemical societies must adapt – here's how to do it
Member organisations need to change their approach to be fit for the 21st century
-
OpinionHow China will tackle its science challenges
Increased creativity and improved recruitment will see China strengthen its claim as the leader in global science
-
BusinessOn the innovation horizon
Bringing disruptive technology to market requires enhanced collaboration
-
BusinessAmgen and Advaxis partner on immuno-oncology
Deal covers rights to system for building cancer therapies specific to a patient’s own tumours
-
BusinessCelgene and Jounce team up against cancer
Firms promise next-generation immuno-oncology as existing drugs rack up successes
-
OpinionNo time for grief over Brexit: we must act
The UK science community must set its priorities in a post-EU world and win over the science sceptics, says John Womersley
-
-
OpinionScience needs safeguards before Brexit occurs
UK researchers must argue loudly and clearly for a settlement that safeguards science
-
BusinessNovartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
